 | • レポートコード：D0GIR-01845 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、子宮筋腫の世界市場を広く調査・分析し、今後の市場展望をまとめております。子宮筋腫の種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（病院、外来手術センター、診断センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Boston Scientific、Siemens Medical Solutions、F. Hoffmann-La Roche、Cooper Surgical、Richard Wolf Medical Instruments、C.R. Bard、AstraZeneca、Karl Storz Endoscopy、GE Healthcare、AbbVie、Johnson & Johnson、Bayer、Novartis、Pfizer、Eli Lilly、GlaxoSmithKline Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・子宮筋腫の北米市場（アメリカ、カナダ、メキシコ） ・子宮筋腫のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・子宮筋腫のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・子宮筋腫の南米市場（ブラジル、アルゼンチン） ・子宮筋腫の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：非ホルモン療法、ホルモン療法 ・用途別分析：病院、外来手術センター、診断センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Uterine Fibroids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Uterine Fibroids market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Uterine Fibroids market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Uterine Fibroids market has been segmented into:
Non-Hormonal Treatment
Hormonal Treatment
By Application, Uterine Fibroids has been segmented into:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Uterine Fibroids market presented in the report. This section sheds light on the sales growth of different regional and country-level Uterine Fibroids markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Uterine Fibroids market.
The report offers in-depth assessment of the growth and other aspects of the Uterine Fibroids market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Uterine Fibroids Market Share Analysis
Uterine Fibroids competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Uterine Fibroids sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Uterine Fibroids sales, revenue and market share for each player covered in this report.
The major players covered in Uterine Fibroids are:
Boston Scientific
Siemens Medical Solutions
F. Hoffmann-La Roche
Cooper Surgical
Richard Wolf Medical Instruments
C.R. Bard
AstraZeneca
Karl Storz Endoscopy
GE Healthcare
AbbVie
Johnson & Johnson
Bayer
Novartis
Pfizer
Eli Lilly
GlaxoSmithKline Pharmaceuticals
Table of Contents
1 Uterine Fibroids Market Overview
1.1 Product Overview and Scope of Uterine Fibroids
1.2 Classification of Uterine Fibroids by Type
1.2.1 Global Uterine Fibroids Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Uterine Fibroids Revenue Market Share by Type in 2019
1.2.3 Non-Hormonal Treatment
1.2.4 Hormonal Treatment
1.3 Global Uterine Fibroids Market by Application
1.3.1 Overview: Global Uterine Fibroids Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Global Uterine Fibroids Market by Regions
1.4.1 Global Uterine Fibroids Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Uterine Fibroids (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Uterine Fibroids Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Uterine Fibroids Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Uterine Fibroids Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Uterine Fibroids Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Uterine Fibroids Status and Prospect (2015-2025)
2 Company Profiles
2.1 Boston Scientific
2.1.1 Boston Scientific Details
2.1.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boston Scientific SWOT Analysis
2.1.4 Boston Scientific Product and Services
2.1.5 Boston Scientific Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.2 Siemens Medical Solutions
2.2.1 Siemens Medical Solutions Details
2.2.2 Siemens Medical Solutions Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Siemens Medical Solutions SWOT Analysis
2.2.4 Siemens Medical Solutions Product and Services
2.2.5 Siemens Medical Solutions Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann-La Roche
2.3.1 F. Hoffmann-La Roche Details
2.3.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann-La Roche SWOT Analysis
2.3.4 F. Hoffmann-La Roche Product and Services
2.3.5 F. Hoffmann-La Roche Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.4 Cooper Surgical
2.4.1 Cooper Surgical Details
2.4.2 Cooper Surgical Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Cooper Surgical SWOT Analysis
2.4.4 Cooper Surgical Product and Services
2.4.5 Cooper Surgical Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.5 Richard Wolf Medical Instruments
2.5.1 Richard Wolf Medical Instruments Details
2.5.2 Richard Wolf Medical Instruments Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Richard Wolf Medical Instruments SWOT Analysis
2.5.4 Richard Wolf Medical Instruments Product and Services
2.5.5 Richard Wolf Medical Instruments Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.6 C.R. Bard
2.6.1 C.R. Bard Details
2.6.2 C.R. Bard Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 C.R. Bard SWOT Analysis
2.6.4 C.R. Bard Product and Services
2.6.5 C.R. Bard Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.7 AstraZeneca
2.7.1 AstraZeneca Details
2.7.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 AstraZeneca SWOT Analysis
2.7.4 AstraZeneca Product and Services
2.7.5 AstraZeneca Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.8 Karl Storz Endoscopy
2.8.1 Karl Storz Endoscopy Details
2.8.2 Karl Storz Endoscopy Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Karl Storz Endoscopy SWOT Analysis
2.8.4 Karl Storz Endoscopy Product and Services
2.8.5 Karl Storz Endoscopy Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.9 GE Healthcare
2.9.1 GE Healthcare Details
2.9.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GE Healthcare SWOT Analysis
2.9.4 GE Healthcare Product and Services
2.9.5 GE Healthcare Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.10 AbbVie
2.10.1 AbbVie Details
2.10.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 AbbVie SWOT Analysis
2.10.4 AbbVie Product and Services
2.10.5 AbbVie Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Johnson & Johnson SWOT Analysis
2.11.4 Johnson & Johnson Product and Services
2.11.5 Johnson & Johnson Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.12 Bayer
2.12.1 Bayer Details
2.12.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Bayer SWOT Analysis
2.12.4 Bayer Product and Services
2.12.5 Bayer Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.13 Novartis
2.13.1 Novartis Details
2.13.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Novartis SWOT Analysis
2.13.4 Novartis Product and Services
2.13.5 Novartis Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.14 Pfizer
2.14.1 Pfizer Details
2.14.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Pfizer SWOT Analysis
2.14.4 Pfizer Product and Services
2.14.5 Pfizer Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.15 Eli Lilly
2.15.1 Eli Lilly Details
2.15.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Eli Lilly SWOT Analysis
2.15.4 Eli Lilly Product and Services
2.15.5 Eli Lilly Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
2.16 GlaxoSmithKline Pharmaceuticals
2.16.1 GlaxoSmithKline Pharmaceuticals Details
2.16.2 GlaxoSmithKline Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GlaxoSmithKline Pharmaceuticals SWOT Analysis
2.16.4 GlaxoSmithKline Pharmaceuticals Product and Services
2.16.5 GlaxoSmithKline Pharmaceuticals Uterine Fibroids Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Uterine Fibroids Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Uterine Fibroids Players Market Share
3.2.2 Top 10 Uterine Fibroids Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Uterine Fibroids Revenue and Market Share by Regions
4.2 North America Uterine Fibroids Revenue and Growth Rate (2015-2020)
4.3 Europe Uterine Fibroids Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Uterine Fibroids Revenue and Growth Rate (2015-2020)
4.5 South America Uterine Fibroids Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Uterine Fibroids Revenue and Growth Rate (2015-2020)
5 North America Uterine Fibroids Revenue by Countries
5.1 North America Uterine Fibroids Revenue by Countries (2015-2020)
5.2 USA Uterine Fibroids Revenue and Growth Rate (2015-2020)
5.3 Canada Uterine Fibroids Revenue and Growth Rate (2015-2020)
5.4 Mexico Uterine Fibroids Revenue and Growth Rate (2015-2020)
6 Europe Uterine Fibroids Revenue by Countries
6.1 Europe Uterine Fibroids Revenue by Countries (2015-2020)
6.2 Germany Uterine Fibroids Revenue and Growth Rate (2015-2020)
6.3 UK Uterine Fibroids Revenue and Growth Rate (2015-2020)
6.4 France Uterine Fibroids Revenue and Growth Rate (2015-2020)
6.5 Russia Uterine Fibroids Revenue and Growth Rate (2015-2020)
6.6 Italy Uterine Fibroids Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Uterine Fibroids Revenue by Countries
7.1 Asia-Pacific Uterine Fibroids Revenue by Countries (2015-2020)
7.2 China Uterine Fibroids Revenue and Growth Rate (2015-2020)
7.3 Japan Uterine Fibroids Revenue and Growth Rate (2015-2020)
7.4 Korea Uterine Fibroids Revenue and Growth Rate (2015-2020)
7.5 India Uterine Fibroids Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Uterine Fibroids Revenue and Growth Rate (2015-2020)
8 South America Uterine Fibroids Revenue by Countries
8.1 South America Uterine Fibroids Revenue by Countries (2015-2020)
8.2 Brazil Uterine Fibroids Revenue and Growth Rate (2015-2020)
8.3 Argentina Uterine Fibroids Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Uterine Fibroids by Countries
9.1 Middle East & Africa Uterine Fibroids Revenue by Countries (2015-2020)
9.2 Saudi Arabia Uterine Fibroids Revenue and Growth Rate (2015-2020)
9.3 UAE Uterine Fibroids Revenue and Growth Rate (2015-2020)
9.4 Egypt Uterine Fibroids Revenue and Growth Rate (2015-2020)
9.5 South Africa Uterine Fibroids Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Uterine Fibroids Revenue and Market Share by Type (2015-2020)
10.2 Global Uterine Fibroids Market Forecast by Type (2019-2024)
10.3 Non-Hormonal Treatment Revenue Growth Rate (2015-2025)
10.4 Hormonal Treatment Revenue Growth Rate (2015-2025)
11 Global Uterine Fibroids Market Segment by Application
11.1 Global Uterine Fibroids Revenue Market Share by Application (2015-2020)
11.2 Uterine Fibroids Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Uterine Fibroids Market Size Forecast (2021-2025)
12.1 Global Uterine Fibroids Market Size Forecast (2021-2025)
12.2 Global Uterine Fibroids Market Forecast by Regions (2021-2025)
12.3 North America Uterine Fibroids Revenue Market Forecast (2021-2025)
12.4 Europe Uterine Fibroids Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Uterine Fibroids Revenue Market Forecast (2021-2025)
12.6 South America Uterine Fibroids Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Uterine Fibroids Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Uterine Fibroids Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Uterine Fibroids by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Uterine Fibroids Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Uterine Fibroids Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Boston Scientific Corporate Information, Location and Competitors
Table 6. Boston Scientific Uterine Fibroids Major Business
Table 7. Boston Scientific Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 8. Boston Scientific SWOT Analysis
Table 9. Boston Scientific Uterine Fibroids Product and Solutions
Table 10. Boston Scientific Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Siemens Medical Solutions Corporate Information, Location and Competitors
Table 12. Siemens Medical Solutions Uterine Fibroids Major Business
Table 13. Siemens Medical Solutions Uterine Fibroids Total Revenue (USD Million) (2018-2019)
Table 14. Siemens Medical Solutions SWOT Analysis
Table 15. Siemens Medical Solutions Uterine Fibroids Product and Solutions
Table 16. Siemens Medical Solutions Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 18. F. Hoffmann-La Roche Uterine Fibroids Major Business
Table 19. F. Hoffmann-La Roche Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 20. F. Hoffmann-La Roche SWOT Analysis
Table 21. F. Hoffmann-La Roche Uterine Fibroids Product and Solutions
Table 22. F. Hoffmann-La Roche Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Cooper Surgical Corporate Information, Location and Competitors
Table 24. Cooper Surgical Uterine Fibroids Major Business
Table 25. Cooper Surgical Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 26. Cooper Surgical SWOT Analysis
Table 27. Cooper Surgical Uterine Fibroids Product and Solutions
Table 28. Cooper Surgical Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Richard Wolf Medical Instruments Corporate Information, Location and Competitors
Table 30. Richard Wolf Medical Instruments Uterine Fibroids Major Business
Table 31. Richard Wolf Medical Instruments Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 32. Richard Wolf Medical Instruments SWOT Analysis
Table 33. Richard Wolf Medical Instruments Uterine Fibroids Product and Solutions
Table 34. Richard Wolf Medical Instruments Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. C.R. Bard Corporate Information, Location and Competitors
Table 36. C.R. Bard Uterine Fibroids Major Business
Table 37. C.R. Bard Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 38. C.R. Bard SWOT Analysis
Table 39. C.R. Bard Uterine Fibroids Product and Solutions
Table 40. C.R. Bard Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. AstraZeneca Corporate Information, Location and Competitors
Table 42. AstraZeneca Uterine Fibroids Major Business
Table 43. AstraZeneca Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 44. AstraZeneca SWOT Analysis
Table 45. AstraZeneca Uterine Fibroids Product and Solutions
Table 46. AstraZeneca Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Karl Storz Endoscopy Corporate Information, Location and Competitors
Table 48. Karl Storz Endoscopy Uterine Fibroids Major Business
Table 49. Karl Storz Endoscopy Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 50. Karl Storz Endoscopy SWOT Analysis
Table 51. Karl Storz Endoscopy Uterine Fibroids Product and Solutions
Table 52. Karl Storz Endoscopy Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. GE Healthcare Corporate Information, Location and Competitors
Table 54. GE Healthcare Uterine Fibroids Major Business
Table 55. GE Healthcare Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 56. GE Healthcare SWOT Analysis
Table 57. GE Healthcare Uterine Fibroids Product and Solutions
Table 58. GE Healthcare Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. AbbVie Corporate Information, Location and Competitors
Table 60. AbbVie Uterine Fibroids Major Business
Table 61. AbbVie Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 62. AbbVie SWOT Analysis
Table 63. AbbVie Uterine Fibroids Product and Solutions
Table 64. AbbVie Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Johnson & Johnson Corporate Information, Location and Competitors
Table 66. Johnson & Johnson Uterine Fibroids Major Business
Table 67. Johnson & Johnson Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 68. Johnson & Johnson SWOT Analysis
Table 69. Johnson & Johnson Uterine Fibroids Product and Solutions
Table 70. Johnson & Johnson Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Bayer Corporate Information, Location and Competitors
Table 72. Bayer Uterine Fibroids Major Business
Table 73. Bayer Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 74. Bayer SWOT Analysis
Table 75. Bayer Uterine Fibroids Product and Solutions
Table 76. Bayer Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Novartis Corporate Information, Location and Competitors
Table 78. Novartis Uterine Fibroids Major Business
Table 79. Novartis Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 80. Novartis SWOT Analysis
Table 81. Novartis Uterine Fibroids Product and Solutions
Table 82. Novartis Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Pfizer Corporate Information, Location and Competitors
Table 84. Pfizer Uterine Fibroids Major Business
Table 85. Pfizer Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 86. Pfizer SWOT Analysis
Table 87. Pfizer Uterine Fibroids Product and Solutions
Table 88. Pfizer Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Eli Lilly Corporate Information, Location and Competitors
Table 90. Eli Lilly Uterine Fibroids Major Business
Table 91. Eli Lilly Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 92. Eli Lilly SWOT Analysis
Table 93. Eli Lilly Uterine Fibroids Product and Solutions
Table 94. Eli Lilly Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. GlaxoSmithKline Pharmaceuticals Corporate Information, Location and Competitors
Table 96. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Major Business
Table 97. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Total Revenue (USD Million) (2017-2018)
Table 98. GlaxoSmithKline Pharmaceuticals SWOT Analysis
Table 99. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Product and Solutions
Table 100. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Global Uterine Fibroids Revenue (Million USD) by Players (2015-2020)
Table 102. Global Uterine Fibroids Revenue Share by Players (2015-2020)
Table 103. Global Uterine Fibroids Revenue (Million USD) by Regions (2015-2020)
Table 104. Global Uterine Fibroids Revenue Market Share by Regions (2015-2020)
Table 105. North America Uterine Fibroids Revenue by Countries (2015-2020)
Table 106. North America Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Table 107. Europe Uterine Fibroids Revenue (Million USD) by Countries (2015-2020)
Table 108. Asia-Pacific Uterine Fibroids Revenue (Million USD) by Countries (2015-2020)
Table 109. South America Uterine Fibroids Revenue by Countries (2015-2020)
Table 110. South America Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Table 111. Middle East and Africa Uterine Fibroids Revenue (Million USD) by Countries (2015-2020)
Table 112. Middle East and Africa Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Table 113. Global Uterine Fibroids Revenue (Million USD) by Type (2015-2020)
Table 114. Global Uterine Fibroids Revenue Share by Type (2015-2020)
Table 115. Global Uterine Fibroids Revenue Forecast by Type (2021-2025)
Table 116. Global Uterine Fibroids Revenue by Application (2015-2020)
Table 117. Global Uterine Fibroids Revenue Share by Application (2015-2020)
Table 118. Global Uterine Fibroids Revenue Forecast by Application (2021-2025)
Table 119. Global Uterine Fibroids Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Uterine Fibroids Picture
Figure 2. Global Uterine Fibroids Revenue Market Share by Type in 2019
Figure 3. Non-Hormonal Treatment Picture
Figure 4. Hormonal Treatment Picture
Figure 5. Uterine Fibroids Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Diagnostic Centers Picture
Figure 9. Others Picture
Figure 10. Global Uterine Fibroids Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Uterine Fibroids Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Uterine Fibroids Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Uterine Fibroids Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Uterine Fibroids Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Uterine Fibroids Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Uterine Fibroids Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Uterine Fibroids Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Uterine Fibroids Revenue Market Share in 2019
Figure 19. Global Top 10 Players Uterine Fibroids Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Uterine Fibroids Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Uterine Fibroids Revenue Market Share by Regions (2015-2020)
Figure 23. Global Uterine Fibroids Revenue Market Share by Regions in 2018
Figure 24. North America Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 25. Europe Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 27. South America Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 29. North America Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Figure 30. North America Uterine Fibroids Revenue Market Share by Countries in 2019
Figure 31. USA Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 32. Canada Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 34. Europe Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Uterine Fibroids Revenue Market Share by Countries in 2019
Figure 36. Germany Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 37. UK Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 38. France Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 39. Russia Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 40. Italy Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Uterine Fibroids Revenue Market Share by Countries in 2019
Figure 43. China Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 44. Japan Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 45. Korea Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 46. India Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 48. South America Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Figure 49. South America Uterine Fibroids Revenue Market Share by Countries in 2019
Figure 50. Brazil Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Uterine Fibroids Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Uterine Fibroids Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 55. UAE Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Uterine Fibroids Revenue and Growth Rate (2015-2020)
Figure 58. Global Uterine Fibroids Revenue Share by Type (2015-2020)
Figure 59. Global Uterine Fibroids Revenue Share by Type in 2019
Figure 60. Global Uterine Fibroids Market Share Forecast by Type (2021-2025)
Figure 61. Global Non-Hormonal Treatment Revenue Growth Rate (2015-2020)
Figure 62. Global Hormonal Treatment Revenue Growth Rate (2015-2020)
Figure 63. Global Uterine Fibroids Revenue Share by Application (2015-2020)
Figure 64. Global Uterine Fibroids Revenue Share by Application in 2019
Figure 65. Global Uterine Fibroids Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Uterine Fibroids Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Uterine Fibroids Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Uterine Fibroids Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Uterine Fibroids Revenue Market Forecast (2021-2025)
Figure 74. Europe Uterine Fibroids Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Uterine Fibroids Revenue Market Forecast (2021-2025)
Figure 76. South America Uterine Fibroids Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Uterine Fibroids Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
子宮筋腫治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Uterine Fibroid Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…- 子宮がん診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Uterine Cancer Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Uterine Can…
- 子宮マニピュレータ装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Uterine Manipulator Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Uterine Manipulat…
- ホルモン避妊薬組み合わせ剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Combined Hormonal Contraceptives market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 20710 million by 2025, from USD 18300 million in 2019. The Combi…
- 末梢血管ガイドワイヤーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Peripheral Vascular Guidewire market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…